What is the recommendation for the use of cilostazol for secondary stroke prevention in patients with ischemic stroke related to small vessel disease?
The recommendation is that the usefulness of cilostazol for secondary stroke prevention in patients with ischemic stroke related to small vessel disease is supported. Prior investigative studies have assessed the impact of BP control and antiplatelet therapy on stroke recurrence after stroke related to small vessel disease and these studies generally support the use of antiplatelet therapy and BP recommendations referenced in relevant sections of this report.